152 related articles for article (PubMed ID: 25380034)
1. Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activity.
Clark-Knowles KV; Dewar-Darch D; Jardine KE; McBurney MW
PLoS One; 2014; 9(11):e112406. PubMed ID: 25380034
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancer.
Clark-Knowles KV; Dewar-Darch D; Jardine KE; McBurney MW
PLoS One; 2013; 8(11):e82106. PubMed ID: 24278473
[TBL] [Abstract][Full Text] [Related]
3. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
4. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
Wang RH; Zheng Y; Kim HS; Xu X; Cao L; Luhasen T; Lee MH; Xiao C; Vassilopoulos A; Chen W; Gardner K; Man YG; Hung MC; Finkel T; Deng CX
Mol Cell; 2008 Oct; 32(1):11-20. PubMed ID: 18851829
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
6. SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol.
Boily G; He XH; Pearce B; Jardine K; McBurney MW
Oncogene; 2009 Aug; 28(32):2882-93. PubMed ID: 19503100
[TBL] [Abstract][Full Text] [Related]
7. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW
Cancer Res; 2005 Nov; 65(22):10363-70. PubMed ID: 16288026
[TBL] [Abstract][Full Text] [Related]
8. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells.
Deus CM; Serafim TL; Magalhães-Novais S; Vilaça A; Moreira AC; Sardão VA; Cardoso SM; Oliveira PJ
Arch Toxicol; 2017 Mar; 91(3):1261-1278. PubMed ID: 27358235
[TBL] [Abstract][Full Text] [Related]
10. SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice.
Seifert EL; Caron AZ; Morin K; Coulombe J; He XH; Jardine K; Dewar-Darch D; Boekelheide K; Harper ME; McBurney MW
FASEB J; 2012 Feb; 26(2):555-66. PubMed ID: 22006156
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
13. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
14. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
15. Obesity Weighs down Memory through a Mechanism Involving the Neuroepigenetic Dysregulation of Sirt1.
Heyward FD; Gilliam D; Coleman MA; Gavin CF; Wang J; Kaas G; Trieu R; Lewis J; Moulden J; Sweatt JD
J Neurosci; 2016 Jan; 36(4):1324-35. PubMed ID: 26818519
[TBL] [Abstract][Full Text] [Related]
16. Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.
Buhrmann C; Shayan P; Popper B; Goel A; Shakibaei M
Nutrients; 2016 Mar; 8(3):145. PubMed ID: 26959057
[TBL] [Abstract][Full Text] [Related]
17. Dietary Supplementation with Methylseleninic Acid Inhibits Mammary Tumorigenesis and Metastasis in Male MMTV-PyMT Mice.
Sundaram S; Yan L
Biol Trace Elem Res; 2018 Jul; 184(1):186-195. PubMed ID: 29032404
[TBL] [Abstract][Full Text] [Related]
18. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.
Wang RH; Sengupta K; Li C; Kim HS; Cao L; Xiao C; Kim S; Xu X; Zheng Y; Chilton B; Jia R; Zheng ZM; Appella E; Wang XW; Ried T; Deng CX
Cancer Cell; 2008 Oct; 14(4):312-23. PubMed ID: 18835033
[TBL] [Abstract][Full Text] [Related]
19. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
20. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
